CS209915B2 - Method of making the 4-halogenpregna-1,4-dien-3,20-dions - Google Patents

Method of making the 4-halogenpregna-1,4-dien-3,20-dions Download PDF

Info

Publication number
CS209915B2
CS209915B2 CS792305A CS230579A CS209915B2 CS 209915 B2 CS209915 B2 CS 209915B2 CS 792305 A CS792305 A CS 792305A CS 230579 A CS230579 A CS 230579A CS 209915 B2 CS209915 B2 CS 209915B2
Authority
CS
Czechoslovakia
Prior art keywords
diene
dione
hydroxy
methyl
chloro
Prior art date
Application number
CS792305A
Other languages
Czech (cs)
English (en)
Inventor
Francisco S Alvarez
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of CS209915B2 publication Critical patent/CS209915B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CS792305A 1978-04-05 1979-04-04 Method of making the 4-halogenpregna-1,4-dien-3,20-dions CS209915B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89364178A 1978-04-05 1978-04-05

Publications (1)

Publication Number Publication Date
CS209915B2 true CS209915B2 (en) 1981-12-31

Family

ID=25401847

Family Applications (1)

Application Number Title Priority Date Filing Date
CS792305A CS209915B2 (en) 1978-04-05 1979-04-04 Method of making the 4-halogenpregna-1,4-dien-3,20-dions

Country Status (16)

Country Link
EP (1) EP0004766A3 (ja)
JP (1) JPS54135762A (ja)
AR (1) AR224124A1 (ja)
AT (1) ATA251679A (ja)
AU (1) AU4575379A (ja)
CS (1) CS209915B2 (ja)
DK (1) DK136379A (ja)
ES (1) ES479269A1 (ja)
FI (1) FI791080A (ja)
GR (1) GR66483B (ja)
IL (1) IL56989A0 (ja)
IT (1) IT7967708A0 (ja)
NO (1) NO791143L (ja)
PL (1) PL214677A1 (ja)
PT (1) PT69410A (ja)
ZA (1) ZA791637B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340538A (en) * 1980-07-21 1982-07-20 The Upjohn Company Process for producing 6α-fluoro-Δ1,4 -3-keto steroids
CN103391945B (zh) * 2011-03-15 2016-11-09 奇斯药制品公司 异噁唑烷衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125591A (en) * 1964-03-17 Derivatives thereof
FR1273890A (fr) * 1960-05-14 1961-10-20 Chimiotherapie Lab Franc Procédé de préparation de stéroïdes 21-bromés
US3169131A (en) * 1963-03-29 1965-02-09 Upjohn Co Process for the preparation of 4-fluorohydrocortisone, 21-acylates and 16-substituted derivatives thereof, and intermediates produced in the preparation thereof

Also Published As

Publication number Publication date
PL214677A1 (ja) 1980-01-02
EP0004766A3 (en) 1979-10-31
GR66483B (ja) 1981-03-24
FI791080A (fi) 1979-10-06
JPS54135762A (en) 1979-10-22
IL56989A0 (en) 1979-07-25
AU4575379A (en) 1979-10-11
PT69410A (fr) 1979-04-01
DK136379A (da) 1979-10-06
IT7967708A0 (it) 1979-04-04
ES479269A1 (es) 1980-01-16
AR224124A1 (es) 1981-10-30
ATA251679A (de) 1982-04-15
EP0004766A2 (en) 1979-10-17
NO791143L (no) 1979-10-08
ZA791637B (en) 1980-11-26

Similar Documents

Publication Publication Date Title
EP0004773B1 (en) 17-beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes, their pharmaceutical use and processes for their preparation
EP0004741B1 (en) Thio etianic acid derivatives, their preparation and pharmaceutical use
US4267173A (en) Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
US4076708A (en) Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby
US4187301A (en) 17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
US4172132A (en) 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
US4226862A (en) Steroids and process for preparing the same
US4336200A (en) 17α-Acyloxy-5β-corticoids
EP0029151B1 (en) 6-alpha-fluoro-9-alpha-chloro-prednisolone-17,21 diesters, pharmaceutical compositions containing them and intermediates
US4024131A (en) 16-Methyl-9α-halo steroid esters, ethers and preparation thereof
US4318853A (en) 9β,11β-Epoxy-5β-corticoids
EP0001864A1 (en) Novel 6-oxygenated-3,20-dioxo-pregnane derivatives, process for the preparation thereof, and pharmaceutical compositions containing them
US4655971A (en) Novel process for the preparation of steroidal esters
CS209915B2 (en) Method of making the 4-halogenpregna-1,4-dien-3,20-dions
DK146017B (da) Analogifremgangsmaade til fremstilling af 17alfa-acyloxy-9alfa,21-dihalogen-11beta-hydroxy-6alfa-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-forbindelser
US4427591A (en) Reduced A ring-Δ9(11) -corticoids
US4232013A (en) 16,17-Pyrazolino- and 16,17-isopyrazolino-1,4-pregnadiene derivatives
US4273770A (en) 4-Halo steroids
US4278669A (en) 3-Oxo-4-halo-16β-methylandrost-4-ene 17β-carboxylic acids and esters
IE43979B1 (en) 21-acetals and mixed acetals of steroidal 21-aldehydes,intermediates and methods of preparation
CS208494B2 (en) Method of making the alcylesters of the 4-halogen-3-oxoandrosta-1,4-dien-17 beta-cyrboxyl acid
JP2004538294A (ja) ６α−フルオロプレグナンの立体選択的製造方法および中間体
JPS5855157B2 (ja) プレグナンケイノ ２− ブロモ −６ ベ−タ − フルオロ −３− ケト − １，４− ステロイドノセイホウ
Ayer et al. Reduced A ring-Δ 9 (11)-corticoids
JPS5938239B2 (ja) 新規ステロイド化合物